LCP2, EIF4EBP1, HCK, and PPP4C were demonstrated to be highly expressed, and SYNJ2 was demonstrated to be lowly expressed in atherosclerosis compared to the control group, which can be diagnostic biomarkers for patients with atherosclerosis (Figure 7A; Supplementary Figure S7). The gene discussed is SYNJ2; the disease is atherosclerosis.